Zepp Health Corporation (ZEPP)
NYSE:ZEPP
Want to see ZEPP full AI Analyst Report?
ZEPP Stock Chart & Stats
$16.76
$0.05(1.72%)
At close: 4:00 PM EST
$16.76
$0.05(1.72%)
Day’s Range― - ―
52-Week Range$2.25 - $61.85
Previous CloseN/A
Volume1.93K
Average Volume (3M)181.25K
Market Cap
$68.85M
Enterprise Value$1.60B
Total Cash (Recent Filing)$789.70M
Total Debt (Recent Filing)$1.59B
Price to Earnings (P/E)―
Beta1.02
Next Earnings
Aug 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-90.67
Shares Outstanding8,460,126
10 Day Avg. Volume307,230
30 Day Avg. Volume181,252
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.12
Price to Sales (P/S)0.10
P/FCF Ratio-1.01
Enterprise Value/Market Cap23.18
Enterprise Value/Revenue0.87
Enterprise Value/Gross Profit2.25
Enterprise Value/Ebitda-7.56
Forecast
1Y Price Target
$56.28Price Target Upside235.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.01
Revenue Forecast (FY)$331.24M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained double-digit top-line growth driven by new product launches and broad-based demand indicates improving product-market fit and expanding distribution. Over the next 2–6 months, this revenue momentum supports higher operating leverage and a clearer path to sustained profitability if execution holds.
Premiumization / ASP ImprovementA >20% rise in ASP reflects successful premiumization and pricing power, which structurally boosts gross margins and reduces dependency on unit volume. If the company maintains this mix, it improves durability of margins and long-term customer lifetime value across the wearable ecosystem.
Strategic Partnership & Ecosystem ExpansionA multi-year exclusive partnership with a fitness organizer deepens category reach and creates channels for differentiated device modes and data. This structural tie-up can drive recurring engagement, broaden product monetization (rings, glasses, cameras) and strengthen brand positioning over multiple years.
Bears Say
Ongoing Net LossesMaterial adjusted net losses at scale limit internal funding capacity and extend dependence on financing or balance-sheet actions. Even with narrowing losses, persistent negative profitability reduces strategic flexibility and elevates the risk that investments in product and marketing will not generate sustainable returns within the next several quarters.
Inconsistent Cash GenerationRepeated negative operating and free cash flow indicates the business is not consistently self-funding. Over a 2–6 month horizon this raises the likelihood of further balance-sheet reliance for working capital, constrains reinvestment in R&D/marketing, and makes capital allocation (debt paydown or buybacks) less sustainable if losses persist.
Rising Leverage And Short‑Term Debt ExposureLeverage rising above equity and reclassification of borrowings to short-term increases refinancing and liquidity risk. Higher indebtedness reduces financial flexibility, may raise interest costs, and limits the company's ability to absorb shocks or invest for growth during the multi-quarter recovery toward consistent profitability.
Zepp Health News
ZEPP FAQ
What was Zepp Health Corporation’s price range in the past 12 months?
Zepp Health Corporation lowest stock price was $2.25 and its highest was $61.85 in the past 12 months.
What is Zepp Health Corporation’s market cap?
Zepp Health Corporation’s market cap is $68.85M.
When is Zepp Health Corporation’s upcoming earnings report date?
Zepp Health Corporation’s upcoming earnings report date is Aug 26, 2026 which is in 72 days.
How were Zepp Health Corporation’s earnings last quarter?
Zepp Health Corporation released its earnings results on Jun 09, 2026. The company reported -$0.07 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.07.
Is Zepp Health Corporation overvalued?
According to Wall Street analysts Zepp Health Corporation’s price is currently Undervalued.
Does Zepp Health Corporation pay dividends?
Zepp Health Corporation pays a Notavailable dividend of $0.1 which represents an annual dividend yield of N/A. See more information on Zepp Health Corporation dividends here
What is Zepp Health Corporation’s EPS estimate?
Zepp Health Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zepp Health Corporation have?
Zepp Health Corporation has 8,460,126 shares outstanding.
What happened to Zepp Health Corporation’s price movement after its last earnings report?
Zepp Health Corporation reported an EPS of -$0.07 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -28.641%.
Which hedge fund is a major shareholder of Zepp Health Corporation?
Currently, no hedge funds are holding shares in ZEPP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Zepp Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$56.28 (235.80% Upside)
$56.28 (235.80% Upside)
Blogger Sentiment
Bullish
ZEPP Sentiment 70%
Sector Average ―
Sector Average ―
Crowd Wisdom
Positive
Last 7 Days ▲ 3.7%
Last 30 Days ▼ 1.7%
Last 30 Days ▼ 1.7%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
96.23%
12-Months-Change
Fundamentals
Return on Equity
-17.94%
Trailing 12-Months
Asset Growth
2.67%
Trailing 12-Months
Company Description
Zepp Health Corporation
Headquartered in Hefei, China, and established in 2013, Zepp Health Corporation (known as Huami Corporation until its rebranding in February 2021) is a technology firm specializing in the creation, production, and sale of intelligent wearable devices. Operating predominantly within the People's Republic of China, the company divides its operations into two main segments: Xiaomi Wearable Products and its own-branded products and other ventures. Its diverse product range includes smart bands, watches, and scales, in addition to hearable devices, home fitness equipment like treadmills, sportswear, selected home appliances, and various smartwatch accessories. These offerings are marketed under both the Xiaomi and Amazfit brands. Zepp Health also empowers users with detailed analyses of their collected activity and biometric data, presented through intuitive charts and graphs accessible via its proprietary Zepp Life and Zepp mobile applications.
ZEPP Company Deck
ZEPP Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a predominantly positive operational narrative: strong top-line performance with Q1 revenue up 33.8% YoY, meaningful premiumization (ASP +20% YoY), gross profit expansion (up 35.3%) and market share gains supported by new product launches and a strategic 3‑year HYROX partnership. Management also demonstrated progress on expense discipline (operating loss narrowed) and working capital (inventory down). Key near-term challenges include rising memory costs, unfavorable FX impacts, elevated operating expenses from front‑loaded launches/marketing, sequential margin moderation from a Q4 peak, and potential shipment timing risk that could shift revenue across quarters. Overall, the positive revenue, premiumization, margin resilience YoY and strategic partnerships outweigh the challenges, but the company remains on a path toward profitability rather than currently profitable.View all ZEPP earnings summariesZEPP Stock 12 Month Forecast
Average Price Target
$56.28
▲(235.80% Upside)
Technical Analysis
Ownership Overview
―
Insiders
3.83% Mutual Funds
3.10% Other Institutional Investors
91.22% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---